Biology and clinical relevance of EpCAM
Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mese...
Saved in:
Published in | Cell Stress Vol. 3; no. 6; pp. 165 - 180 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Austria
Shared Science Publishers OG
21.05.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker. |
---|---|
AbstractList | Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker. Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker.Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because EpCAM expression is limited to normal and malignant epithelia, it has been used as diagnostic marker for the detection of carcinoma cells in mesenchymal organs such as blood, bone marrow or lymph nodes. In particular, the detection and molecular characterization of EpCAM-positive circulating tumor cells (CTCs) in the blood of carcinoma patients has gained considerable interest over the past ten years. EpCAM is primarily considered as an adhesion molecule, but recent studies have shown diverse biological functions including regulation of cell proliferation and cancer stemness. In this review, we summarize the current knowledge on the biological properties of EpCAM with emphasis on mechanisms involved in cancer progression and discuss the clinical implications of these findings for the clinical use of EpCAM as a diagnostic marker. |
Author | Keller, Laura Pantel, Klaus Werner, Stefan |
Author_xml | – sequence: 1 givenname: Laura surname: Keller fullname: Keller, Laura – sequence: 2 givenname: Stefan surname: Werner fullname: Werner, Stefan – sequence: 3 givenname: Klaus surname: Pantel fullname: Pantel, Klaus |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31225512$$D View this record in MEDLINE/PubMed https://hal.science/hal-04954701$$DView record in HAL |
BookMark | eNp1ks1PGzEQxS1EBZRy5lbtre0hwd9rXyqlES1IqXopZ8se28HIWafeTST--25IqACpJ1vj936e0bz36LgrXUDokuApEVKrK-gHiomeYjklSh2hMyoom2CK-fGL-ym66PsHjDElUrVCnqBTRigVgtAz9OlbKrksHxvb-QZy6hLY3NSQw9Z2EJoSm-v1fPbzA3oXbe7DxeE8R3ffr3_PbyaLXz9u57PFBLhmwyS6CEC9Y95qSp1SRNEQMbSti1hzHWiUQtPWtcQHDo7iCC3BWsYAXirLztHtnuuLfTDrmla2Pppik3kqlLo0tg4JcjDMw-hijjjhePTBKYGBSM2U2M0OI-vrnrXeuFXwELqh2vwK-vqlS_dmWbZGCqE04yPgyx5w_8Z2M1uYXQ1zLXiLyZaM2s-Hz2r5swn9YFaph5Cz7ULZ9IZSLiQnrcCj9OPLvv6Rn7cyCsReALX0fQ3RQBrskMquzZQNweYpAOYQAIOlGQMw-q7e-J7R_3P8BaGIsPw |
CitedBy_id | crossref_primary_10_1038_s41598_024_83061_8 crossref_primary_10_1016_j_humpath_2020_04_005 crossref_primary_10_1021_jacs_3c02625 crossref_primary_10_1038_s41557_022_01057_1 crossref_primary_10_1002_1878_0261_13092 crossref_primary_10_1186_s13045_022_01347_8 crossref_primary_10_1089_cmb_2020_0364 crossref_primary_10_1515_biol_2022_0780 crossref_primary_10_1038_s41416_023_02179_0 crossref_primary_10_1016_j_snb_2023_133784 crossref_primary_10_1134_S1990750820030099 crossref_primary_10_3390_ijms232314687 crossref_primary_10_1002_cam4_5429 crossref_primary_10_1186_s12935_022_02658_z crossref_primary_10_1016_j_bbrep_2021_101074 crossref_primary_10_1155_ijso_2621591 crossref_primary_10_3390_ijms21249457 crossref_primary_10_18097_pbmc20206601095 crossref_primary_10_2217_pgs_2021_0099 crossref_primary_10_2147_OTT_S386562 crossref_primary_10_3390_pharmaceutics14122561 crossref_primary_10_1007_s12672_025_02095_0 crossref_primary_10_1007_s40291_024_00734_w crossref_primary_10_3390_microorganisms8111753 crossref_primary_10_1016_j_bios_2021_113594 crossref_primary_10_3390_cells9081836 crossref_primary_10_1002_pros_23896 crossref_primary_10_1039_D3AN01011B crossref_primary_10_1016_j_heliyon_2023_e13044 crossref_primary_10_3389_fnmol_2021_809878 crossref_primary_10_3389_fncel_2023_1170309 crossref_primary_10_1016_j_gene_2023_147905 crossref_primary_10_1038_s41392_024_01938_6 crossref_primary_10_3390_cancers12061632 crossref_primary_10_1038_s41598_023_30733_6 crossref_primary_10_1016_j_cpt_2024_01_001 crossref_primary_10_1373_clinchem_2019_303339 crossref_primary_10_1080_17476348_2024_2388288 crossref_primary_10_3390_app10144854 crossref_primary_10_1007_s00281_025_01042_z crossref_primary_10_1007_s40336_021_00444_x crossref_primary_10_3390_photonics9120955 crossref_primary_10_1007_s13258_021_01211_y crossref_primary_10_1016_j_oraloncology_2023_106433 crossref_primary_10_3389_fonc_2022_843879 crossref_primary_10_1021_acs_langmuir_1c01998 crossref_primary_10_1016_j_jncc_2024_07_003 crossref_primary_10_1177_17588359241284935 crossref_primary_10_1016_j_sna_2024_115229 crossref_primary_10_3390_cancers13071719 crossref_primary_10_1038_s41467_021_22482_9 crossref_primary_10_1186_s12935_021_01858_3 crossref_primary_10_1016_j_aca_2025_343623 crossref_primary_10_3390_diagnostics12020497 crossref_primary_10_1021_acsmaterialslett_3c00616 crossref_primary_10_1016_j_talanta_2024_127127 crossref_primary_10_3390_app112210787 crossref_primary_10_3390_cells11162570 crossref_primary_10_1002_smtd_202200717 crossref_primary_10_1016_j_bioadv_2022_213077 crossref_primary_10_1371_journal_pbio_3001394 crossref_primary_10_1016_j_ijom_2021_05_020 crossref_primary_10_1016_j_inoche_2024_112409 crossref_primary_10_1021_jacs_3c09545 crossref_primary_10_12688_f1000research_27393_2 crossref_primary_10_12688_f1000research_27393_1 crossref_primary_10_1080_14712598_2021_1922665 crossref_primary_10_12688_f1000research_27393_3 crossref_primary_10_1007_s10585_021_10120_z crossref_primary_10_3389_fbioe_2020_00897 crossref_primary_10_3390_cells9061361 crossref_primary_10_3389_fendo_2022_941166 crossref_primary_10_1136_jitc_2022_005615 crossref_primary_10_1038_s41467_022_28788_6 crossref_primary_10_1186_s12871_021_01479_3 crossref_primary_10_3389_fbioe_2023_1144209 crossref_primary_10_1093_biomethods_bpaf009 crossref_primary_10_1007_s12672_025_01846_3 crossref_primary_10_3389_fonc_2022_1090503 crossref_primary_10_1038_s41416_024_02576_z crossref_primary_10_1021_acsanm_2c02078 crossref_primary_10_1002_1878_0261_12997 crossref_primary_10_1016_j_bios_2024_116050 crossref_primary_10_1016_j_apmt_2020_100701 crossref_primary_10_3390_chemosensors11060335 crossref_primary_10_3390_cells9071691 crossref_primary_10_1371_journal_pone_0241123 crossref_primary_10_3390_bioengineering9080380 crossref_primary_10_1016_j_semcancer_2020_12_002 crossref_primary_10_1155_2020_4821056 crossref_primary_10_3390_ijms231911983 crossref_primary_10_2174_1381612829666230420083431 crossref_primary_10_4252_wjsc_v12_i11_1295 crossref_primary_10_1080_14728222_2022_2077188 crossref_primary_10_17650_1994_4098_2021_17_4_90_95 crossref_primary_10_3390_cancers14174121 crossref_primary_10_3390_cancers14112810 crossref_primary_10_3389_fcell_2024_1441081 crossref_primary_10_3390_cells9092128 crossref_primary_10_3390_cancers12113328 crossref_primary_10_3390_cancers14194596 crossref_primary_10_1007_s40291_023_00680_z crossref_primary_10_1016_j_bbcan_2024_189236 crossref_primary_10_1186_s12885_020_07580_z crossref_primary_10_1007_s00432_023_04809_9 crossref_primary_10_1016_j_talanta_2023_124548 crossref_primary_10_1016_j_prp_2024_155378 crossref_primary_10_1002_jev2_12039 crossref_primary_10_1021_acsami_0c20916 crossref_primary_10_3390_ijms221910640 crossref_primary_10_1002_smll_202106097 crossref_primary_10_3390_biomedicines10112985 crossref_primary_10_3389_fimmu_2024_1402951 crossref_primary_10_1016_j_colsurfa_2024_135176 crossref_primary_10_15252_emmm_201911908 crossref_primary_10_1016_j_bbrc_2022_01_120 crossref_primary_10_1186_s12951_022_01256_5 crossref_primary_10_1016_j_isci_2021_103179 crossref_primary_10_3389_fonc_2021_672262 crossref_primary_10_3390_diagnostics13162652 crossref_primary_10_1016_j_yexcr_2021_112685 crossref_primary_10_3390_cancers14153595 crossref_primary_10_1007_s10555_020_09898_3 crossref_primary_10_1093_clinchem_hvaa322 crossref_primary_10_1007_s12015_020_10045_2 crossref_primary_10_3390_ijms25137109 crossref_primary_10_1002_admt_202001138 crossref_primary_10_15252_embj_2021109221 crossref_primary_10_3390_diagnostics11030544 crossref_primary_10_3389_fgene_2020_00312 crossref_primary_10_1186_s13072_022_00449_4 crossref_primary_10_7554_eLife_90298 crossref_primary_10_3390_ijms24054554 crossref_primary_10_3390_life11090915 crossref_primary_10_18632_aging_206024 crossref_primary_10_1021_acssensors_2c01750 crossref_primary_10_1007_s00432_023_04767_2 |
ContentType | Journal Article |
Copyright | Distributed under a Creative Commons Attribution 4.0 International License Copyright: © 2019 Keller et al. 2019 |
Copyright_xml | – notice: Distributed under a Creative Commons Attribution 4.0 International License – notice: Copyright: © 2019 Keller et al. 2019 |
DBID | AAYXX CITATION NPM 7X8 1XC 5PM DOA |
DOI | 10.15698/cst2019.06.188 |
DatabaseName | CrossRef PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
DocumentTitleAlternate | EpCAM biology and functions |
EISSN | 2523-0204 |
EndPage | 180 |
ExternalDocumentID | oai_doaj_org_article_3dcfec3b1b5b4fdeb850c1693852523c PMC6558934 oai_HAL_hal_04954701v1 31225512 10_15698_cst2019_06_188 |
Genre | Journal Article Review |
GroupedDBID | AAFWJ AAYXX ADBBV AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION GROUPED_DOAJ HYE M~E OK1 RPM NPM 7X8 1XC 5PM |
ID | FETCH-LOGICAL-c493t-fbfcc2db3da922b88182ef0c77bf0949e2f65927b71de4cb20fc71096fecd68a3 |
IEDL.DBID | DOA |
ISSN | 2523-0204 |
IngestDate | Wed Aug 27 01:21:18 EDT 2025 Thu Aug 21 18:03:07 EDT 2025 Fri May 09 12:17:26 EDT 2025 Fri Jul 11 00:03:19 EDT 2025 Thu Jan 02 23:01:38 EST 2025 Tue Jul 01 00:55:01 EDT 2025 Thu Apr 24 23:02:34 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Tumor biomarker EpCAM circulating tumor cells EMT liquid biopsy tumor cell dissemination |
Language | English |
License | Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 This is an open-access article released under the terms of the Creative Commons Attribution (CC BY) license, which allows the unrestricted use, distribution, and reproduction in any medium, provided the original author and source are acknowledged. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c493t-fbfcc2db3da922b88182ef0c77bf0949e2f65927b71de4cb20fc71096fecd68a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 Please cite this article as: Laura Keller, Stefan Werner and Klaus Pantel (2019). Biology and clinical relevance of EpCAM. Cell Stress 3(6): 165-180. doi: 10.15698/cst2019.06.188 Conflict of interest: K.P. has ongoing patent applications related to circulating tumor cells. K.P. has received honoraria from Agena, Novartis, Roche and Sanofi and research funding from European Federation of Pharmaceutical Industries and Associations (EFPIA) partners (Angle, Menarini and Servier) of the CANCER-ID programme of the European Union–EFPIA Innovative Medicines Initiative. L.K and S.W. declare no conflict of interest. |
OpenAccessLink | https://doaj.org/article/3dcfec3b1b5b4fdeb850c1693852523c |
PMID | 31225512 |
PQID | 2245641750 |
PQPubID | 23479 |
PageCount | 16 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_3dcfec3b1b5b4fdeb850c1693852523c pubmedcentral_primary_oai_pubmedcentral_nih_gov_6558934 hal_primary_oai_HAL_hal_04954701v1 proquest_miscellaneous_2245641750 pubmed_primary_31225512 crossref_citationtrail_10_15698_cst2019_06_188 crossref_primary_10_15698_cst2019_06_188 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20190521 |
PublicationDateYYYYMMDD | 2019-05-21 |
PublicationDate_xml | – month: 5 year: 2019 text: 20190521 day: 21 |
PublicationDecade | 2010 |
PublicationPlace | Austria |
PublicationPlace_xml | – name: Austria |
PublicationTitle | Cell Stress |
PublicationTitleAlternate | Cell Stress |
PublicationYear | 2019 |
Publisher | Shared Science Publishers OG |
Publisher_xml | – name: Shared Science Publishers OG |
SSID | ssj0002168756 |
Score | 2.468528 |
SecondaryResourceType | review_article |
Snippet | Epithelial cell adhesion molecule (EpCAM) is a transmembrane glycoprotein primarily known to mediate homotypic cell contacts in epithelia tissues. Because... |
SourceID | doaj pubmedcentral hal proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 165 |
SubjectTerms | circulating tumor cells EMT EpCAM Life Sciences liquid biopsy Review Tumor biomarker tumor cell dissemination |
Title | Biology and clinical relevance of EpCAM |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31225512 https://www.proquest.com/docview/2245641750 https://hal.science/hal-04954701 https://pubmed.ncbi.nlm.nih.gov/PMC6558934 https://doaj.org/article/3dcfec3b1b5b4fdeb850c1693852523c |
Volume | 3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYqTr1UlL7SQuVWFeVAwHHs2DluEWhVlYoDSNysjB-iUpVF7IK0_56ZJPuiqnrp1bGd5JuxZ0Yef8PYlwC68Y0SuQw25CqCzcHUPkflsQFiLb2n-87nP6vxlfp-ra_XSn1RTlhPD9wDd1wGn6IvoQANKgWcTAtPDCJWSwyiPO2-aPPWginag2VRoSNeDVw-uqrtsZ_O0NjVxNZZdHVWVmaoY-tH43JDuZB_OppP8yXXDNDZNnsxeI581H_xS_Ystjts_6Knnp4f8svVTarpId_nFytS6vkr9rUvOjnnTRv44jokp4opXQ4AnyR-ensyOn_Nrs5OL0_G-VAkIfeqLmd5guS9DFCGppYSLBpgGZPwxkDC0K2OMtHJqQFThKg8SJE85V9WiGqobFO-YVvtpI3vGDcheNFoENFGJQBR0gABpIzGQmNSxo4WmDk_MIhTIYvfjiIJAtkNIDtRORyesYPlgNuePOPvXb-REJbdiPW6a0BdcIMuuH_pQsY-owg35hiPfjhqw0BIKyOKhyJjnxYSdriU6HykaePkfuokHQIr9KdExt72El_OVRa48aFzlDGzoQsbL9t80v666ei6K63RKVTv_8cffmDPCTRKX5DFLtua3d3HPfSKZvCxWwCPTQ4MGA |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Biology+and+clinical+relevance+of+EpCAM&rft.jtitle=Cell+Stress&rft.au=Keller%2C+Laura&rft.au=Werner%2C+Stefan&rft.au=Pantel%2C+Klaus&rft.date=2019-05-21&rft.pub=Shared+Science+Publishers+OG&rft.eissn=2523-0204&rft.volume=3&rft.issue=6&rft.spage=165&rft.epage=180&rft_id=info:doi/10.15698%2Fcst2019.06.188&rft_id=info%3Apmid%2F31225512&rft.externalDocID=PMC6558934 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2523-0204&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2523-0204&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2523-0204&client=summon |